Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × plerixafor × Clear all

NCT04058145 2020-09-07

AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma

Phase 2 Withdrawn

Head and Neck Neoplasms